Edwards Lifesciences stock up 726% in 15 years, beating market
Edwards Lifesciences shares have risen significantly over the last 15 years, turning a $100 investment into $826.43. The stock achieved a 15.06% annualized return, exceeding market performance by 1.31%, with the company now valued at $53.35 billion.

*this image is generated using AI for illustrative purposes only.
Edwards Lifesciences (NYSE: EW) has generated an average annual return of 15.06% over the past 15 years, outperforming the broader market by 1.31% on an annualized basis. The medical device manufacturer currently holds a market capitalization of $53.35 billion.
An investor who purchased $100 of EW stock 15 years ago would see that position grow to $826.43 today. This valuation is based on the company's share price of $92.56 at the time of writing.
Performance Metrics
The long-term performance data highlights the impact of compounded returns on capital growth over extended periods. The key figures from the 15-year period are detailed below:
| Metric: | Value |
|---|---|
| Average Annual Return: | 15.06% |
| Market Outperformance: | 1.31% (annualized) |
| Current Market Cap: | $53.35 billion |
| Current Share Price: | $92.56 |
| 15-Year Growth ($100): | $826.43 |
What the Numbers Show
The divergence between the absolute growth of the investment ($826.43 from $100) and the modest annualized outperformance (1.31%) illustrates the baseline strength of the broader market over this period. While Edwards Lifesciences delivered strong absolute returns, the majority of the total return was driven by general market appreciation rather than alpha generation relative to the benchmark.
Can Edwards Lifesciences sustain its 15% annualized return given the maturing addressable market for transcatheter heart valves?
How might increasing regulatory scrutiny on medical device pricing impact EW's future profit margins and total shareholder return?
What role will emerging competitors in structural heart interventions play in eroding Edwards' current market share over the next decade?






























